Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

The U.S. Food and Drug Administration has approved a nasal spray to treat depression—the first-ever stand-alone medication ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...

PUTRAJAYA, Jan 4 — As cryptocurrencies gain prominence as an alternative to conventional currencies, they have also become a new tool for criminals to facilitate illegal activities. Corruption is ...

MACC aims to wrap up its investigation into the corruption scandal implicating Sabah state leaders before the end of January, according to chief commissioner Azam Baki. Speaking to Malaysiakini ...

A single-center pilot study at the Veterans Affairs Hospital/University of Washington in Seattle reported improved verbal memory retention and attention after a three-week test of 20 international ...